Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Waldman

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Neurology|August 31, 2016
Pediatric multiple sclerosis: Clinical features and outcomeAmy Waldman, Jayne Ness, Daniela Pohl, et al.
Pediatric Neurology|April 25, 2026
Factors Influencing Early and Late B-Cell Repopulation After Rituximab Therapy in Pediatric Central Nervous System Inflammatory DisordersAmaar Marefi, Eleonora A Grasso, Lisa Garber, et al.
Annals of Clinical and Translational Neurology|June 19, 2023
Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxiaLayne N Rodden, Kellie McIntyre, Medina Keita, et al.
Neuroimage|November 15, 2019
Evaluating motor cortical oscillations and age-related change in autism spectrum disorderWilliam Gaetz, Edward Rhodes, Luke Bloy, et al.
AJNR. American Journal of Neuroradiology|May 2, 2024
Brainstem Chipmunk Sign: A Diagnostic Imaging Clue across All Subtypes of Alexander DiseaseThaís Armangue, Matthew T Whitehead, Davide Tonduti, et al.
Pediatric Neurology|October 8, 2021
Reliability of the Telemedicine Application of the Gross Motor Function Measure-88 in Patients With LeukodystrophyFrancesco Gavazzi, Laura Adang, Amy Waldman, et al.
Neurology|August 31, 2016
International Pediatric MS Study Group Global Members Symposium reportEvangeline Wassmer, Tanuja Chitnis, Daniela Pohl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosisCarolyn E Schwartz, Stephanie A Grover, Victoria E Powell, et al.
Human Mutation|March 4, 2020
Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoformGuy Helman, Asako Takanohashi, Tracy L Hagemann, et al.
Human Mutation|August 3, 2022
Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoformGuy Helman, Asako Takanohashi, Tracy L Hagemann, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Neurology|August 31, 2016
Pediatric multiple sclerosis: Clinical features and outcomeAmy Waldman, Jayne Ness, Daniela Pohl, et al.
Pediatric Neurology|April 25, 2026
Factors Influencing Early and Late B-Cell Repopulation After Rituximab Therapy in Pediatric Central Nervous System Inflammatory DisordersAmaar Marefi, Eleonora A Grasso, Lisa Garber, et al.
Annals of Clinical and Translational Neurology|June 19, 2023
Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxiaLayne N Rodden, Kellie McIntyre, Medina Keita, et al.
Neuroimage|November 15, 2019
Evaluating motor cortical oscillations and age-related change in autism spectrum disorderWilliam Gaetz, Edward Rhodes, Luke Bloy, et al.
AJNR. American Journal of Neuroradiology|May 2, 2024
Brainstem Chipmunk Sign: A Diagnostic Imaging Clue across All Subtypes of Alexander DiseaseThaís Armangue, Matthew T Whitehead, Davide Tonduti, et al.
Pediatric Neurology|October 8, 2021
Reliability of the Telemedicine Application of the Gross Motor Function Measure-88 in Patients With LeukodystrophyFrancesco Gavazzi, Laura Adang, Amy Waldman, et al.
Neurology|August 31, 2016
International Pediatric MS Study Group Global Members Symposium reportEvangeline Wassmer, Tanuja Chitnis, Daniela Pohl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosisCarolyn E Schwartz, Stephanie A Grover, Victoria E Powell, et al.
Human Mutation|March 4, 2020
Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoformGuy Helman, Asako Takanohashi, Tracy L Hagemann, et al.
Human Mutation|August 3, 2022
Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoformGuy Helman, Asako Takanohashi, Tracy L Hagemann, et al.
Pageof 6